Business · 08/01/2004Updated: 10/17/2026 · 1 min read
FDA to Review Efficacy of Bacterial Vaccines and Toxoids, a Key Component of Biological Products
Summary
The US Food and Drug Administration (FDA) will conduct a thorough review of the efficacy of bacterial vaccines and toxoids, which are crucial components of biological products, in an effort to ensure their safety and effectiveness for public use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →